Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men

CompletedOBSERVATIONAL
Enrollment

578

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Infection, Human Immunodeficiency VirusHIV Infections
Interventions
BEHAVIORAL

Risk reduction counseling

Subjects will receive comprehensive prevention package including HIV and safe sex counseling, provision of condoms and water-based lubricant, and STI screening and referral for treatment.

OTHER

Social harm interview

Information regarding social harms (loss of privacy, stigmatization, interference with gainful employment, and coercion) will be solicited during bi-monthly study visits after enrollment in the study and will be recorded. Subjects who report social harms will be referred to speak with a social worker and/or a study counselor.

OTHER

Computer-Assisted Self Interviewing technique

Demographic, behavioral, and psychosocial factors associated with HIV acquisition will be assessed by CASI.

Trial Locations (9)

100015

GSK Investigational Site, Beijing

100069

GSK Investigational Site, Beijing

110001

GSK Investigational Site, Shenyang

201508

GSK Investigational Site, Shanghai

310000

GSK Investigational Site, Hangzhou

410005

GSK Investigational Site, Changsha

510060

GSK Investigational Site, Guangzhou

518020

GSK Investigational Site, Shenzhen

610066

GSK Investigational Site, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY